[
    [
        {
            "time": "2023-09-15",
            "original_text": "乐普医疗：心血管器械龙头不忘初心，第二季度业绩恢复明显，看好全年发展",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "心血管器械",
                    "第二季度",
                    "业绩恢复",
                    "全年发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：心血管器械龙头不忘初心，第二季度业绩恢复明显，看好全年发展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-15",
            "original_text": "益丰药房：上半年业绩继续高增长，区域聚焦战略助推公司成长",
            "features": {
                "keywords": [
                    "益丰药房",
                    "上半年",
                    "高增长",
                    "区域聚焦",
                    "战略"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药零售"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "益丰药房：上半年业绩继续高增长，区域聚焦战略助推公司成长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-15",
            "original_text": "医保局下令：最晚3月底，要么交承诺书，要么出局",
            "features": {
                "keywords": [
                    "医保局",
                    "承诺书",
                    "出局"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗政策"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医保局下令：最晚3月底，要么交承诺书，要么出局",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-09-15",
            "original_text": "国产PD-1企业半年报比拼，信达生物进医保后放量明显",
            "features": {
                "keywords": [
                    "国产PD-1",
                    "信达生物",
                    "医保",
                    "放量"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国产PD-1企业半年报比拼，信达生物进医保后放量明显",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-15",
            "original_text": "恒瑞医药：脯氨酸恒格列净片联合厄贝沙坦治疗合并高血压的2型糖尿病肾病获批临床试验",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "脯氨酸恒格列净片",
                    "临床试验",
                    "高血压",
                    "糖尿病肾病"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药：脯氨酸恒格列净片联合厄贝沙坦治疗合并高血压的2型糖尿病肾病获批临床试验",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-15",
            "original_text": "麦格理：上调石药目标价至21.1港元，评级跑赢大市",
            "features": {
                "keywords": [
                    "麦格理",
                    "石药",
                    "目标价",
                    "跑赢大市"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "麦格理：上调石药目标价至21.1港元，评级跑赢大市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-09-15",
            "original_text": "碘造影剂龙头司太立中报业绩亮眼，净利润同比大增50%",
            "features": {
                "keywords": [
                    "司太立",
                    "碘造影剂",
                    "中报",
                    "净利润",
                    "同比大增"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "碘造影剂龙头司太立中报业绩亮眼，净利润同比大增50%",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]